Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Appointed CFO
Quarterly results
Appointed director

GALECTIN THERAPEUTICS INC (GALT) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 ARS Form ARS - Annual Report to Security Holders:
10/06/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
10/06/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
10/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/27/2023 4 Uihlein Richard E (10% Owner) has filed a Form 4 on GALECTIN THERAPEUTICS INC
Txns: Exercised 1,466,204 warrants @ $5, valued at $7.3M
Exercised 170,000 warrants @ $5, valued at $850k
Exercised 200,000 warrants @ $3, valued at $600k
Exercised 200,000 warrants @ $3.26, valued at $652k
08/15/2023 4 LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC
Txns: Granted 12,042 shares @ $1.6, valued at $19.3k
08/14/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "NORCROSS, Georgia, August 14, 2023 –"
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/31/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/03/2023 4 LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC
Txns: Granted 13,380 shares @ $1.44, valued at $19.3k
06/16/2023 4 LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC
Txns: Granted 13,196 shares @ $1.46, valued at $19.3k
06/01/2023 4 LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC
Txns: Granted 12,272 shares @ $1.57, valued at $19.3k
05/16/2023 4 LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC
Txns: Granted 11,748 shares @ $1.64, valued at $19.3k
05/15/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "NORCROSS, Georgia, May 15, 2023 –"
05/15/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/09/2023 4 LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC
Txns: Granted 10,947 shares @ $1.76, valued at $19.3k
04/25/2023 EFFECT Form EFFECT - Notice of Effectiveness:
04/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/14/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
04/03/2023 4 LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC
Txns: Granted 9,175 shares @ $2.1, valued at $19.3k
03/30/2023 8-K Quarterly results
03/30/2023 10-K Annual Report for the period ended December 31, 2022
03/16/2023 4 LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC
Txns: Granted 10,140 shares @ $1.9, valued at $19.3k
03/02/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "NORCROSS, Ga., March 2, 2023"
03/02/2023 4 LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC
Txns: Granted 9,308 shares @ $2.07, valued at $19.3k
Paid exercise price by delivering 75,529 shares @ $2.07, valued at $156.3k
02/07/2023 4 LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC
Txns: Granted 143,836 shares @ $1.43, valued at $205.7k
01/31/2023 4 LEWIS JOEL (President and CEO) has filed a Form 4 on GALECTIN THERAPEUTICS INC
Txns: Granted 15,086 shares @ $1.16, valued at $17.5k
01/31/2023 5 10X Fund, L.P. (10% Owner) has filed a Form 5 on GALECTIN THERAPEUTICS INC
01/30/2023 4 Zordani Richard A. Jr. (Director) has filed a Form 4 on GALECTIN THERAPEUTICS INC
Txns: Granted 40,000 options to buy @ $1.11, valued at $44.4k
01/30/2023 4 Shlevin Harold H. (Director) has filed a Form 4 on GALECTIN THERAPEUTICS INC
Txns: Granted 40,000 options to buy @ $1.11, valued at $44.4k
01/30/2023 4 Schwartz Elissa J. (Director) has filed a Form 4 on GALECTIN THERAPEUTICS INC
Txns: Granted 40,000 options to buy @ $1.11, valued at $44.4k
01/30/2023 4 Rubin Marc (Director) has filed a Form 4 on GALECTIN THERAPEUTICS INC
Txns: Granted 40,000 options to buy @ $1.11, valued at $44.4k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy